Previsioni di mercato per la scoperta di anticorpi nell\'Asia Pacifica fino al 2030 - Analisi regionale - per tipo di anticorpo (anticorpi monoclonali, anticorpi policlonali e altri), natura (umano e umanizzato, chimerico e murino), servizi (Phage Display, ibridoma, animale transgenico, cellula singola e Yeast Display) e utente finale (aziende farmaceutiche e biotecnologiche, laboratori di ricerca e altri)

BMIRE00030716 | Pages: 90 | Biotechnology | Sep 2024 | Type: Regional | Status: Published
Il mercato della scoperta di anticorpi nell\'Asia Pacifica è stato valutato a 6.58.965,05 milioni di dollari nel 2022 e si prevede che raggiungerà 11.58.681,86 milioni di dollari entro il 2030; si stima che registrerà un CAGR del 7,3% dal 2022 al 2030.

La proliferazione dell\'industria biotecnologica nelle regioni in via di sviluppo stimola il mercato della scoperta di anticorpi nell\'Asia Pacifica

La straordinaria precisione degli anticorpi nell\'identificazione degli antigeni li rende strumenti inestimabili per scienziati e clinici. Nella moderna biotecnologia, gli anticorpi sono richiesti in numerosi processi, dalla ricerca di base alle valutazioni mediche innovative. Lo sviluppo di anticorpi terapeutici ha aperto nuove strade nel trattamento di varie malattie, dimostrando la capacità trasformativa di queste particelle. Gli anticorpi sono inoltre cruciali nella diagnostica basata sugli anticorpi in quanto forniscono approcci accurati e affidabili all\'identificazione delle malattie. Il crescente supporto da parte dei governi, l\'aumento delle partnership pubblico-private, i profili di malattia in continuo cambiamento e le crescenti attività di finanziamento stanno ampiamente migliorando le prestazioni delle industrie biotecnologiche in regioni come l\'Asia Pacifica.

Secondo l\'Organizzazione per la cooperazione e lo sviluppo economico (OCSE), la Cina era un\'azienda leader in termini di spesa in R&S a partire dal 2019. Investimenti ingenti incoraggiano l\'adozione di tecnologie avanzate nel settore sanitario. I governi di paesi in regioni come l\'Asia offrono incentivi fiscali, terreni più economici e investimenti diretti per incoraggiare le aziende biotecnologiche ad espandere le proprie capacità e rafforzare le proprie competenze. Pertanto, paesi come Taiwan, Malesia, India, Cina, Singapore e Giappone sono tra le destinazioni più vantaggiose per le industrie biotecnologiche. Inoltre, questi paesi asiatici sono maggiormente concentrati sull\'uso della genomica, della proteomica e dei progressi dei biomarcatori per applicazioni diagnostiche e terapeutiche. Pertanto, si prevede che la continua proliferazione delle industrie biotecnologiche nelle regioni in via di sviluppo creerà opportunità per il mercato della scoperta di anticorpi nei prossimi anni.

Panoramica del mercato della scoperta di anticorpi nell\'Asia Pacifica

Il mercato della scoperta di anticorpi nell\'Asia Pacifica è suddiviso in Cina, Giappone, India, Corea del Sud, Australia e resto dell\'Asia Pacifica. La Cina ha rappresentato la quota maggiore del mercato nel 2022 e si prevede che l\'India registrerà un CAGR significativo nel mercato durante il periodo di previsione. L\'industria biofarmaceutica in Cina sta subendo un enorme cambiamento, evolvendosi da un panorama incentrato sui farmaci generici a un fiorente polo di innovazione. Inoltre, i progressi nell\'industrializzazione e l\'applicazione di nuovi farmaci, dispositivi medici di fascia alta e tecniche contribuiscono alla crescita del mercato della scoperta di anticorpi in Cina.

La Cina sta vivendo un\'impennata nella prevalenza di malattie cardiovascolari e altre malattie croniche. Secondo il Journal of Biomedical and Environmental Science, quasi 330 milioni di persone nel paese hanno sofferto di malattie cardiovascolari nel 2021. I prodotti anticorpali sono fondamentali per lo sviluppo di nuove terapie contro le malattie cardiovascolari. Pertanto, una crescente prevalenza di malattie cardiache innesca la necessità di scoperta di anticorpi. Con l\'aiuto dei centri di ricerca, è possibile ricercare sequenze di anticorpi, sviluppare anticorpi nuovi e innovativi e ottimizzare gli anticorpi esistenti. Secondo la classifica Scimago Institute, la Cina aveva circa 170 centri di ricerca medica nel 2022, seguita da Giappone (72), Australia (53) e India (17). Inoltre, il crescente numero di operatori di mercato che si concentrano sui paesi dell\'Asia Pacifica per la loro espansione geografica e altre strategie di crescita, il numero crescente di centri di ricerca e un notevole aumento dei finanziamenti governativi alimentano la crescita del mercato della scoperta di anticorpi nell\'Asia Pacifica.

Entrate e previsioni del mercato della scoperta di anticorpi nell\'Asia Pacifica fino al 2030 (miliardi di dollari USA)

Segmentazione del mercato della scoperta di anticorpi nell\'Asia Pacifica

Il mercato della scoperta di anticorpi nell\'Asia Pacifica è categorizzato in base a tipo di anticorpo, natura, servizi, utente finale e paese.

In base al tipo di anticorpo, il mercato della scoperta di anticorpi nell\'Asia Pacifica è segmentato in anticorpi monoclonali, anticorpi policlonali e altri. Il segmento degli anticorpi monoclonali ha detenuto la quota di mercato più grande per la scoperta di anticorpi nell\'Asia Pacifica nel 2022.

In termini di natura, il mercato della scoperta di anticorpi nell\'Asia Pacifica è suddiviso in umano e umanizzato, chimerico e murino. Il segmento umano e umanizzato ha detenuto la quota di mercato più grande per la scoperta di anticorpi nell\'Asia Pacifica nel 2022.

In base ai servizi, il mercato della scoperta di anticorpi nell\'Asia Pacifica è suddiviso in phage display, ibridoma, animale transgenico, cellula singola e lievito display. Il segmento phage display ha detenuto la quota di mercato più grande per la scoperta di anticorpi nell\'Asia Pacifica nel 2022.

In base all\'utente finale, il mercato della scoperta di anticorpi nell\'Asia Pacifica è suddiviso in aziende farmaceutiche e biotecnologiche, laboratori di ricerca e altri. Il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto la quota di mercato più grande per la scoperta di anticorpi nell\'Asia Pacifica nel 2022.

In base al paese, il mercato della scoperta di anticorpi nell\'Asia Pacifica è suddiviso in Cina, Giappone, India, Corea del Sud, Australia e resto dell\'Asia Pacifica. La Cina ha dominato la quota di mercato della scoperta di anticorpi nell\'area Asia-Pacifico nel 2022.

Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp e Biocytogen Pharmaceuticals Beijing Co Ltd. sono alcune delle aziende leader che operano nel mercato della scoperta di anticorpi nell\'area Asia-Pacifico.

1.        Introduction

1.1      The Insight Partners Research Report Guidance

1.2      Market Segmentation

2.        Executive Summary

2.1      Key Insights

3.        Research Methodology

3.1      Coverage

3.2      Secondary Research

3.3      Primary Research

4.        Asia Pacific Antibody Discovery Market – Key Market Dynamics

4.1      Asia Pacific Antibody Discovery Market – Key Market Dynamics

4.2      Market Drivers

4.2.1       Increasing Investments in Research & Development

4.2.2       Rising Incidence of Cancer

4.3      Market Restraints

4.3.1       High Cost of Production

4.4      Market Opportunities

4.4.1       Proliferation of Biotechnology Industry in Developing Regions

4.5      Future Trends

4.5.1       Developments for Custom Antibodies

4.6      Impact of Drivers and Restraints:

5.        Antibody Discovery Market – Asia Pacific Market Analysis

5.1      Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020–2030

6.        Asia Pacific Antibody Discovery Market Analysis – by Antibody Type

6.1      Overview

6.2      Monoclonal Antibodies

6.2.1       Overview

6.2.2       Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

6.3      Polyclonal Antibodies

6.3.1       Overview

6.3.2       Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

6.4      Others

6.4.1       Overview

6.4.2       Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

7.        Asia Pacific Antibody Discovery Market Analysis – by Nature

7.1      Overview

7.2      Human and Humanized

7.2.1       Overview

7.2.2       Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

7.3      Chimeric

7.3.1       Overview

7.3.2       Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

7.4      Murine

7.4.1       Overview

7.4.2       Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

8.        Asia Pacific Antibody Discovery Market Analysis – by Services

8.1      Overview

8.2      Phage Display

8.2.1       Overview

8.2.2       Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

8.3      Hybridoma

8.3.1       Overview

8.3.2       Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

8.4      Transgenic Animal

8.4.1       Overview

8.4.2       Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030  (US$ Million)

8.5      Yeast Display

8.5.1       Overview

8.5.2       Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

8.6      Single Cell

8.6.1       Overview

8.6.2       Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

9.        Asia Pacific Antibody Discovery Market Analysis – by End User

9.1      Overview

9.2      Pharmaceutical and Biotechnology Companies

9.2.1       Overview

9.2.2       Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

9.3      Research Laboratories

9.3.1       Overview

9.3.2       Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

9.4      Others

9.4.1       Overview

9.4.2       Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.      Asia Pacific Antibody Discovery Market – Country Analysis

10.1    Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030

10.1.1     Asia Pacific: Antibody Discovery Market – Revenue and Forecast Analysis – by Country

10.1.1.1       China

10.1.1.1.1      Overview

10.1.1.1.2      China: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3      China: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.1.4      China: Antibody Discovery Market Breakdown, by Nature

10.1.1.1.5      China: Antibody Discovery Market Breakdown, by Services

10.1.1.1.6      China: Antibody Discovery Market Breakdown, by End User

10.1.1.2       Japan

10.1.1.2.1      Overview

10.1.1.2.2      Japan: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3      Japan: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.2.4      Japan: Antibody Discovery Market Breakdown, by Nature

10.1.1.2.5      Japan: Antibody Discovery Market Breakdown, by Services

10.1.1.2.6      Japan: Antibody Discovery Market Breakdown, by End User

10.1.1.3       India

10.1.1.3.1      Overview

10.1.1.3.2      India: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3      India: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.3.4      India: Antibody Discovery Market Breakdown, by Nature

10.1.1.3.5      India: Antibody Discovery Market Breakdown, by Services

10.1.1.3.6      India: Antibody Discovery Market Breakdown, by End User

10.1.1.4       Australia

10.1.1.4.1      Overview

10.1.1.4.2      Australia: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3      Australia: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.4.4      Australia: Antibody Discovery Market Breakdown, by Nature

10.1.1.4.5      Australia: Antibody Discovery Market Breakdown, by Services

10.1.1.4.6      Australia: Antibody Discovery Market Breakdown, by End User

10.1.1.5       South Korea

10.1.1.5.1      Overview

10.1.1.5.2      South Korea: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3      South Korea: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.5.4      South Korea: Antibody Discovery Market Breakdown, by Nature

10.1.1.5.5      South Korea: Antibody Discovery Market Breakdown, by Services

10.1.1.5.6      South Korea: Antibody Discovery Market Breakdown, by End User

10.1.1.6       Rest of Asia Pacific

10.1.1.6.1      Overview

10.1.1.6.2      Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3      Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.6.4      Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature

10.1.1.6.5      Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services

10.1.1.6.6      Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User

11.      Antibody Discovery Market-Industry Landscape

11.1    Overview

11.2    Growth Strategies in the Antibody Discovery Market

11.3    Inorganic Growth Strategies

11.3.1     Overview

11.4    Organic Growth Strategies

11.4.1     Overview

12.      Company Profiles

12.1    Charles River Laboratories International Inc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    BioDuro LLC

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Sartorius AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Aragen Life Sciences Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Twist Bioscience Corp

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Biocytogen Pharmaceuticals Beijing Co Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

13.      Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms

 

 

 

List of Tables

Table 1.          Asia Pacific Antibody Discovery Market Segmentation

Table 2.          New Cancer Cases Worldwide, in 2020

Table 3.          China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type

Table 4.          China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature

Table 5.          China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services

Table 6.          China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 7.          Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type

Table 8.          Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature

Table 9.          Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services

Table 10.        Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 11.        India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type

Table 12.        India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature

Table 13.        India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services

Table 14.        India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 15.        Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type

Table 16.        Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature

Table 17.        Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services

Table 18.        Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 19.        South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type

Table 20.        South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature

Table 21.        South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services

Table 22.        South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 23.        Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type

Table 24.        Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature

Table 25.        Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services

Table 26.        Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 27.        Recent Inorganic Growth Strategies in the Antibody Discovery Market

Table 28.        Recent Organic Growth Strategies in the Antibody Discovery Market

Table 29.        Glossary of Terms, Antibody Discovery Market

 

 

List of Figures

Figure 1.         Asia Pacific Antibody Discovery Market Segmentation, by Country

Figure 2.         Impact Analysis of Drivers and Restraints

Figure 3.         Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 – 2030

Figure 4.         Asia Pacific Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)

Figure 5.         Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 6.         Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.         Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.         Asia Pacific Antibody Discovery Market Share (%) – by Nature (2022 and 2030)

Figure 9.         Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.      Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.      Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.      Asia Pacific Antibody Discovery Market Share (%) – by Services (2022 and 2030)

Figure 13.      Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030  (US$ Million)

Figure 14.      Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.      Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.      Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.      Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.      Asia Pacific Antibody Discovery Market Share (%) – by End User (2022 and 2030)

Figure 19.      Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.      Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.      Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.      Asia Pacific: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)

Figure 23.      Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 24.      China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)

Figure 25.      Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)

Figure 26.      India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)

Figure 27.      Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)

Figure 28.      South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)

Figure 29.      Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)

Figure 30.      Growth Strategies in the Antibody Discovery Market

 

 

  1. Charles River Laboratories International Inc
  2. BioDuro LLC
  3. Sartorius AG
  4. Aragen Life Sciences Ltd
  5. Twist Bioscience Corp
  6. Biocytogen Pharmaceuticals Beijing Co Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibody discovery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific antibody discovery market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440